See Tai Sandi
- SEC CIK
- 0002009350
In the past year, 2 open-market sale filings worth $38.4K and no purchases.
Current role at each company
- LXEO Lexeo Therapeutics, Inc.Chief Development Officeras of Nov 20, 2025
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $38.4K
- 2 filings
- Net
- −$38.4K
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists See Tai Sandi as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Nov 20, 2025 (view filing) | Nov 18 | 2 days | See Tai SandiChief Development Officer | SSale | −386 | $9.27 | −$3.58K | −0.6%65.5K after | |
| Oct 17, 2025 (view filing) | Oct 17 | Same day | See Tai SandiChief Development Officer | SSale | −3.89K | $8.95 | −$34.8K | −5.6%65.9K after | 2 lots |
| Aug 20, 2025 (view filing) | Aug 18 | 2 days | See Tai SandiChief Development Officer | SSale | −382 | $4.67 | −$1.78K | −0.6%58.9K after | |
| May 20, 2025 (view filing) | May 16 | 4 days | See Tai SandiChief Development Officer | SSale | −367 | $2.77 | −$1.02K | −0.6%59.2K after | |
| Feb 21, 2025 (view filing) | Feb 19 | 2 days | See Tai SandiChief Development Officer | SSale | −1.49K | $4.41 | −$6.55K | −2.7%53.9K after |